Integral Derivatives’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-23,542
Closed -$1.94M 1306
2017
Q3
$1.92M Buy
23,542
+1,192
+5% +$95.7K 0.04% 323
2017
Q2
$1.77M Buy
+22,350
New +$1.7M 0.04% 331
2016
Q3
Sell
-4,500
Closed -$331K 1178
2016
Q2
$323K Buy
+4,500
New +$317K 0.01% 725
2015
Q4
Sell
-7,050
Closed -$467K 1255
2015
Q3
$467K Buy
+7,050
New +$515K 0.01% 731
2014
Q2
Sell
-11,900
Closed -$699K 1545
2014
Q1
$696K Buy
+11,900
New +$686K 0.01% 774

Other funds holding XLV

Integral Derivatives's XLV Position: Q4 2017 in Review

Integral Derivatives sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2017, closing a stake of 23,542 shares — an estimated $1.94M sold.

Integral Derivatives first reported a position in XLV in Q1 2014 and held it in 5 quarters. The position peaked at $1.92M in Q3 2017. 769 funds tracked by Wall St. Rank hold XLV as of Q4 2017.

  • Integral Derivatives reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 23,542 State Street Health Care Select Sector SPDR ETF shares in Q4 2017, an estimated $1.94M.
  • Integral Derivatives first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2014 and held it in 5 quarters.
  • Integral Derivatives's State Street Health Care Select Sector SPDR ETF position peaked at $1.92M in Q3 2017.
  • 769 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.